Score Overview
Pacific Biosciences of California fundamental performance
Between 2020 and 2025, revenue grew from $ 78M to $ 160M and net income went from $ 29M to -$ 546M. Revenue increased in 2 of those 5 years; net income in 2.
Across Pacific Biosciences of California's full reported history, from 2010 to 2025, revenue grew from $ 1M to $ 160M and net income went from -$ 140M to -$ 546M. Revenue increased in 56% of the years measured; net income in 56%.
Pacific Biosciences of California currently holds a 5-year HDB Score of 4.0 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 1.11 | — |
1 Year2025-08-12 | $ 1.21 | -8.26% |
5 Years2021-08-12 | $ 30.59 | -96.37% |
10 Years2016-08-12 | $ 8.27 | -86.58% |
All Time2010-10-27 | $ 16.44 | -93.25% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | All Time2010-10-27 |
|---|---|---|---|---|---|
| Price | $ 1.11 | $ 1.21 | $ 30.59 | $ 8.27 | $ 16.44 |
| Return | — | -8.26% | -96.37% | -86.58% | -93.25% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 159M | -$ 131M | $ 61M |
| 2025 | $ 160M | -$ 546M | $ 279M |
| 2024 | $ 154M | -$ 309M | $ 389M |
| 2023 | $ 200M | -$ 306M | $ 631M |
| 2022 | $ 128M | -$ 314M | $ 772M |
| 2021 | $ 130M | -$ 181M | $ 1.04B |
| 2020 | $ 78M | $ 29M | $ 318M |
| 2019 | $ 90M | -$ 84M | $ 49M |
| 2018 | $ 78M | -$ 102M | $ 102M |
| 2017 | $ 93M | -$ 92M | $ 62M |
| 2016 | $ 90M | -$ 74M | $ 71M |
| 2015 | $ 92M | -$ 31M | $ 82M |
| 2014 | $ 60M | -$ 66M | $ 101M |
| 2013 | $ 28M | -$ 79M | $ 112M |
| 2012 | $ 25M | -$ 94M | $ 100M |
| 2011 | $ 33M | -$ 109M | $ 177M |
| IPO2010 | $ 1M | -$ 140M | $ 283M |
Explore beyond PACB
You're looking at Pacific Biosciences of California. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
